David Malcom Rodman, Chief Medical Officer at Mineralys Therapeutics, sold MLYS on Jun 12, 2026
Data as of Oct 16
▼ SELL$152K6,349 shares at $23.93David Malcom Rodman Chief Medical OfficerMLYS Mineralys Therapeutics, Inc.
- Traded
- Jun 12, 2026
- Disclosed
- Jun 12, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
MLYS since disclosure
−14.1%
after the sale
Similar stocks (XLV) since disclosure
+14.9%
XLV — its sector index fund
Change in closing price from Jun 12, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLDavid Malcom Rodman Chief Medical OfficerMLYS Mineralys Therapeutics, Inc.$54.3Kdisclosed Jun 12 · filed 2 days after the trade